Bionexus Gene La (BGLC) Free Cash Flow by Year
Bionexus Gene La recorded an outflow of $1.9M in free cash flow in fiscal year 2025. This represents an increase of 19.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to an outflow of $854K in free cash flow. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Bionexus Gene La has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BGLC Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
BGLC Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Bionexus Gene La financials
Frequently Asked Questions
What was Bionexus Gene La's free cash flow in fiscal year 2025?
Bionexus Gene La recorded an outflow of $1.9M in free cash flow in fiscal year 2025.
How fast is Bionexus Gene La's free cash flow growing?
Bionexus Gene La (BGLC) free cash flow rose by 19.2% year over year, from -$2.3M to -$1.9M in fiscal year 2025.
What is Bionexus Gene La's free cash flow over the last twelve months?
Bionexus Gene La (BGLC) reported an outflow of $854K in free cash flow over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Bionexus Gene La's free cash flow changed over the years?
Across the 8 fiscal years this page covers, Bionexus Gene La (BGLC) free cash flow went from -$314K in fiscal year 2018 to -$1.9M in fiscal year 2025.
What was Bionexus Gene La's free cash flow in the most recent quarter?
Bionexus Gene La (BGLC) reported -$423K in free cash flow in Q2 2026. This represents an increase of 44.3% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Bionexus Gene La (BGLC) reported on that line in every period on record.